Chewy Inc
F:3HH
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Chewy Inc
F:3HH
|
US |
|
H
|
Homology Medicines Inc
F:35H
|
US |
|
AAA Allgemeine Anlageverwaltung AG
F:AAA
|
DE |
|
G
|
Global Net Lease Inc
F:2N8
|
US |
Wall St Price Targets
3HH Price Targets Summary
Chewy Inc
According to Wall Street analysts, the average 1-year price target for 3HH is 58.94 EUR with a low forecast of 37.58 EUR and a high forecast of 78.14 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is 3HH's stock price target?
Price Target
58.94
EUR
According to Wall Street analysts, the average 1-year price target for 3HH is 58.94 EUR with a low forecast of 37.58 EUR and a high forecast of 78.14 EUR.
What is the Revenue forecast for Chewy Inc?
Projected CAGR
9%
Over the last 8 years, the compound annual growth rate for Revenue has been 25%. The projected CAGR for the next 3 years is 9%.
What is the Gross Profit forecast for Chewy Inc?
Projected CAGR
10%
Over the last 8 years, the compound annual growth rate for Gross Profit has been 34%. The projected CAGR for the next 3 years is 10%.
What is the Operating Income forecast for Chewy Inc?
Projected CAGR
48%
The compound annual growth rate for Operating Income over the next 3 years is 48%.
What is the Pre-Tax Income forecast for Chewy Inc?
Projected CAGR
46%
The compound annual growth rate for Pre-Tax Income over the next 3 years is 46%.
What is the Net Income forecast for Chewy Inc?
Projected CAGR
66%
The compound annual growth rate for Net Income over the next 3 years is 66%.
